Table 2 10-year cardiovascular disease (CVD) baseline risk scores of 210 left-sided breast cancer patients
From: Heart sparing radiotherapy in breast cancer: the importance of baseline cardiac risks
10-year-CVD risk (%) | Non-Diabetic patients (n = 200) | Diabetic patients (n = 10) | ||
|---|---|---|---|---|
Procam Score | ||||
≤1 | 90 | (45%) | 1 | (10%) |
1.1–4.9 | 76 | (38%) | 3 | (30%) |
5–9.9 | 16 | (8%) | 1 | (10%) |
10–19.9 | 15 | (7.5%) | 3 | (30%) |
> 20 | 3 | (1.5%) | 2 | (20%) |
mean | 3.11 | 11.76 | ||
95% CI | 2.39–3.83 | 2.86–20.65 | ||
Framingham Score | ||||
≤1 | 92 | (46%) | 0 | |
1.1–4.9 | 53 | (26.5%) | 1 | (10%) |
5–9.9 | 39 | (19.5%) | 2 | (20%) |
10–19.9 | 15 | (7.5%) | 2 | (20%) |
> 20 | 1 | (0.5%) | 5 | (50%) |
mean | 3.39 | 24.23 | ||
95% CI | 2.88–3.90 | 13.79–34.67 | ||
Reynolds Score | ||||
≤1 | 96 | (48%) | 1 | (10%) |
1.1–4.9 | 53 | (26.5%) | 4 | (40%) |
5–9.9 | 35 | (17.5%) | 0 | |
10–19.9 | 13 | (6.5%) | 3 | (30%) |
> 20 | 3 | (1.5%) | 2 | (20%) |
mean | 3.58 | 10.66 | ||
95% CI | 2.92–4.23 | 3.89–17.43 | ||